Gene polymorphisms | OR | 95% CI | P | I2(%) | Models |
---|---|---|---|---|---|
On lung cancer risk | |||||
 rs189037 | |||||
  AA + AG vs. GG | 1.10 | 0.99–1.22 | 0.08 | 8.7 | Fixed |
  AA vs. AG + GG | 1.16 | 1.03–1.32 | 0.02 | 19.9 | Fixed |
  AA vs. GG | 1.21 | 1.04–1.39 | 0.01 | 32.7 | Fixed |
  AG vs. GG | 1.06 | 0.95–1.19 | 0.30 | 0 | Fixed |
  A vs. G | 1.09 | 1.02–1.17 | 0.01 | 29.2 | Fixed |
 rs664677 | |||||
  TT + TC vs. CC | 1.01 | 0.89–1.14 | 0.88 | 0 | Fixed |
  TT vs. TC + CC | 1.26 | 1.06–1.49 | 0.01 | 1.1 | Fixed |
  TT vs. CC | 1.20 | 0.98–1.46 | 0.08 | 0.0 | Fixed |
  TC vs. CC | 0.96 | 0.83–1.11 | 0.60 | 0.0 | Fixed |
  T vs. C | 1.08 | 0.98–1.18 | 0.12 | 9.7 | Fixed |
 rs664143 | |||||
  AA + AG vs. GG | 1.43 | 1.18–1.73 | 0 | 0 | Fixed |
  AA vs. AG + GG | 1.10 | 0.95–1.27 | 0.20 | 0 | Fixed |
  AA vs. GG | 1.43 | 1.15–1.78 | <0.01 | 0 | Fixed |
  AG vs. GG | 1.43 | 1.17–1.75 | <0.01 | 0 | Fixed |
  A vs. G | 1.15 | 1.04–1.28 | <0.01 | 0 | Fixed |
 rs609429 | |||||
  AA vs. AG + GG | 0.97 | 0.72–1.32 | 0.85 | 59.3 | Random |
On RP risk | |||||
 rs189037 | |||||
  AA + AG vs. GG | 1.72 | 1.18–2.52 | <0.01 | 2.6 | Fixed |
  AA vs. AG + GG | 1.34 | 0.67–2.66 | 0.57 | 57.4 | Random |
  AA vs. GG | 1.74 | 1.02–2.97 | 0.04 | 35.8 | Fixed |
  AG vs. GG | 1.48 | 0.92–2.37 | 0.11 | 23.2 | Fixed |
  A vs. G | 0.57 | 0.18–1.77 | 0.33 | 97.5 | Random |